Press Releases

 Filter by Provider

【Global Finance Newswire】AlphaKJ, a leading global primary-market incubation platform for digital assets, has officially unveiled its latest global strategic blueprint. Positioned as a “Global Alpha Asset Incubation Hub,” AlphaKJ is powered by three core engines: deep source-stage incubation, standardized IDO fundraising and issuance, and a global launch matrix. Together, these capabilities create a rapid, integrated cycle spanning early-stage project development, token issuance, institutional capital introduction, and global liquidity, opening a new chapter for the development of the digital asset primary market.

Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today published its monthly origination volume for July 2026 and its latest Upstart Macro Index (UMI) reading. For historical data and more information, see upstart.com/volume and upstart.com/umi.

Transaction in Own Shares

HONG KONG, HK / ACCESS Newswire / August 3, 2026 / Traveling in 2026 and 2027 feels simpler in a lot of ways. Getting online once you leave home? That part can still go sideways fast if you are stuck with roaming, an airport SIM queue, or whatever free Wi-Fi you can find.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Running a successful salon today involves much more than offering excellent beauty services. Clients expect convenience, quick responses, and the ability to book appointments whenever it suits them. As customer expectations continue to evolve, salons that still rely on phone calls, text messages, or Instagram direct messages for appointments often struggle to keep up. Online […]

LOI contemplates exclusive worldwide rights to market, promote, resell and distribute Nebo Holdings Limited’s Preempt OSINT platform to operators of data centers

Boston, Massachusetts--(Newsfile Corp. - August 3, 2026) - GoingClear, a Boston-based digital agency, is celebrating its 25th anniversary, marking a...

Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson

MEX Exchange, the institutional electronic trading platform of MultiBank Group, today announced the appointment of Vibhanshu Bahuguna as Senior Director, reinforcing the company's commitment to building a world-class leadership team as it expands its global institutional business and technology capabilities.

BOSTON and BEDFORD, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Curium™, a leading, global radiopharmaceutical company with proven expertise in the development, manufacturing and supply of radiopharmaceuticals that improve the way cancer is diagnosed and treated, and Lantheus Holdings, Inc. ("Lantheus" or "Company") (NASDAQ: LNTH), today announced that Curium US Holdings LLC (“Curium US”) and Lantheus have entered into a definitive agreement under which Lantheus, a leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, will merge with a wholly-owned subsidiary of Curium US.

Las Vegas, Nevada--(Newsfile Corp. - August 3, 2026) -  DLT Resolution Inc. (OTCID: DLTI) today announced that it has acquired...

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

London, United Kingdom--(Newsfile Corp. - August 3, 2026) - Visuable, an award-winning Squarespace web design and SEO agency, has launched...

Lantern Pharma Inc. (Nasdaq: LTRN), a clinical-stage AI-driven precision oncology company, today announced the formal creation of Open-Medicine AI (OMAI) and the execution of commercial licensing agreements between OMAI and Lantern Pharma. The agreements, which have received Lantern Pharma Board approval, are consistent with the framework outlined in Lantern’s most recent registered direct financing and establish the commercial operating structure for the multi-agentic AI co-scientist platform previously launched as withZeta.ai.

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Distribution Solutions Group, Inc. (“DSG” or “the Company”) (NASDAQ: DSGR) for potential breaches of fiduciary duty on the part of its directors and management.

Cinemark Holdings, Inc. (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced that July 31 through August 2 was the biggest domestic weekend box office of all time for the company, propelled by the sensational opening of Spider-Man: Brand New Day, with additional contribution from The Odyssey’s strong holdover performance. Additionally, the web-slinging success of Spider-Man: Brand New Day delivered Cinemark’s best-ever domestic box office for a three-day opening weekend, surpassing the previous record set by Avengers: Endgame.

As educators across the country prepare to welcome students back to the classroom, Horace Mann is launching its annual Ready. Set. Inspire. back-to-school campaign, providing more than $65,000 in classroom funding, educator giveaways and financial resources to help educators start the school year strong.

Krispy Kreme, Inc. (NASDAQ: DNUT) (“Krispy Kreme” or the “Company”) today announced the appointment of Suk Nicholas as Chief Commercial Officer and Lori Suess as Chief People Officer, effective August 3, 2026.

CLEVELAND, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

Nasdaq letter confirms that HUB Security has satisfied the applicable continued-listing requirement and closed the matter

The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

PALO ALTO, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its second quarter 2026 financial results and business update after the market closes on Monday, August 10, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.

Dr. Mehmud’s appointment further aligns the scientific, clinical, regulatory and operational leadership of Antev

EVelution Energy LLC (“EVelution Energy” or the “Company”), a U.S. critical minerals company developing America’s first commercial-scale, solar-powered cobalt sulfate and cobalt metal processing facility, today announced that the Export-Import Bank of the United States (“EXIM”) has re-issued its non-binding Letter of Interest (“LOI”), increasing proposed financing support for the Company’s Arizona cobalt processing facility from up to US$200 million to up to US$275 million under EXIM’s Make More in America (“MMIA”) initiative.

MONTREAL, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Bombardier announced today its industry-leading Challenger 3500 will be on display at the Latin American Business Aviation Conference & Exhibition 2026 (LABACE) Aug. 4–6 at Campo de Marte Airport in São Paulo, revealing its impressive design and performance attributes for clients in region.

SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Thursday, August 13, 2026, at 1:30 p.m. PT / 4:30 p.m. ET. During the call, Donn Casale, President and Chief Executive Officer, will outline the Company’s updated strategic priorities and report second quarter 2026 financial results.

WALTHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 19,425 shares of the Company’s ordinary shares to one non-executive employee as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on July 31, 2026 and were material to the employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).

AMC Entertainment Holdings, Inc. (NYSE: AMC), the largest theatrical exhibitor in the United States and the world, today announced that the Company generated the highest total revenue in the U.S. and globally in AMC history during a single weekend – Wednesday through Sunday – including the highest ever admissions revenue, and the highest ever food & beverage revenue. SPIDER-MAN: BRAND NEW DAY debuted Wednesday at ODEON Cinemas internationally and Thursday at domestic AMC theatres.

A new international analysis has found that the age-standardized alcohol-attributable mortality rate has fallen by approximately 26% worldwide since 2010, the baseline established following the adoption of the UN’s Global Strategy to Reduce the Harmful Use of Alcohol, adding to growing evidence that meaningful reductions in alcohol-related harm are achievable over time.1

MOU marks the first data center step in KIDZ AI's demand-led, inference-focused neocloud strategy, targeting deployment of a dedicated NVIDIA Blackwell B300 GPU cluster purpose-built for high-throughput, cost-efficient inference on open-weight AI models at the DFW3 data center in Dallas, Texas

SES AI Corp. (NYSE: SES) (“SES AI” or the “Company”), a leader in AI-enhanced Li-Metal and Li-ion batteries, today announced that it has entered into a framework agreement with Doroni Aerospace, developer of the H1-X two-seat personal electric vertical takeoff and landing (eVTOL) aircraft, to design, develop, test and deliver a battery pack for Doroni Aerospace’s H1-X. The framework agreement establishes an aggregate price of up to $1,090,000, of which the initial tranche of $65,000 is committed, for work planned over multiple stages in 2026 and 2027, with each stage to be triggered by the issuance of a purchase order from Doroni to SES AI.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the third quarter fiscal 2026 ended June 30, 2026.

LONDON and GAITHERSBURG, Md., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced preliminary second quarter 2026 AUCATZYL net product revenue of approximately $45 million and gross margin of approximately 35% year-to-date. Autolus also announced that it has entered into a strategic financing with Perceptive Advisors (“Perceptive”), a leading global healthcare specialist investor, for the sale of notes of up to $250 million in aggregate principal amount in a five-year, interest-only senior credit facility (the “Credit Facility”), subject to certain conditions. An initial $75 million principal amount of notes has been issued by Autolus to Perceptive on July 30, 2026, and an additional $25 million in aggregate principal amount will be available at Autolus’ option for up to six months post-closing. An additional $150 million in aggregate principal amount of subsequent capital may become available in separate tranches upon achievement of certain pre-specified revenue milestones.   

OwlPay Harbor payment volume has now increased for six consecutive months, as contracted enterprise clients steadily expanded their use of the platform

Biocon Limited (BSE: 532523; NSE: BIOCON), an innovation‑led global biopharmaceutical company, today announced the commercial launch of Yesafili™ (aflibercept-jbvf) in the United States. YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor used to treat various types of ophthalmology conditions, is a biosimilar of its reference product EYLEA® (aflibercept) 2 mg. The product was approved previously and granted interchangeable designation* by the U.S. Food and Drug Administration in May 2024, allowing substitution at the pharmacy level in accordance with state laws.

SPOKANE, Wash., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today reported the following results for the second quarter of 2026 and the six months ended June 30, 2026 as compared to the respective periods in 2025 (dollars in millions, except per-share amounts):

ROCKVILLE, Md., Aug. 03, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or “the Company”), a leading developer of advanced nuclear reactors and fuel technology, and SGL Carbon (“SGL”) today announced a binding agreement to double SGL’s production capacity for medium-grain isotropic graphite (“NBG-18”), a specialized material central to X-energy’s Xe-100 high-temperature gas-cooled reactor (“HTGR”). X-energy and SGL’s (together, the “Companies”) agreement would expand the supply chain for a critical long-lead material, supporting execution of X-energy’s 11+ GW commercial pipeline.

Rocket Pharmaceuticals, Inc. (Rocket or the Company) (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and devastating diseases, focused on inherited cardiovascular disorders, today announced a positive clinical safety update regarding the initial three patients treated under the modified protocol for its global, pivotal Phase 2 trial of RP-A501 in Danon disease. Early safety has been promising with the Company now engaging with the U.S. Food and Drug Administration (FDA) to align on the pathway for treating additional patients and completing the pivotal Phase 2 trial under the modified protocol.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to zocilurtatug pelitecan (zoci, formerly ZL-1310), the Company’s potential first-in-class Delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), for the treatment of neuroendocrine carcinomas (NECs). NECs are aggressive malignancies that frequently express DLL3. There are no available targeted therapies and no approved standard of care for NECs in previously treated patients.

Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced the appointments of Matthew Leoni, M.D., as Chief Medical Officer, Gan Wei, Ph.D., as Chief Technical Officer, and Heidi Henson as a member of its Board of Directors, where she will serve as Chair of the Audit Committee. Collectively, these appointments strengthen Korsana's leadership team as the Company advances KRSA-028, its lead THETA™-enabled therapeutic candidate for Alzheimer's disease, toward clinical development while continuing to progress its pipeline of potential best-in-class therapies for neurodegenerative diseases.

Bally's Corporation (NYSE: BALY) today announced the successful closing of its acquisition of Sam's Town Shreveport from Boyd Gaming, marking another milestone in the company's continued investment in Louisiana and expansion of its regional gaming and entertainment portfolio.

KKR, a leading global investment firm, today announced the final closing of KKR Global Infrastructure Investors V (“Fund V” or the “Fund”), a $19.2 billion Core+ fund focused on investing in critical infrastructure assets and businesses primarily in North America and Western Europe. Fund V, the fifth vintage in KKR’s Global Infrastructure Strategy, is KKR’s largest infrastructure fund raised to date. Fund V contributes to approximately $45 billion raised across KKR’s latest infrastructure vehicle vintages globally.

Seaport Therapeutics, Inc., (Nasdaq: SPTX) (“Seaport” or the “Company”), a clinical-stage therapeutics company that is inventing and developing novel neuropsychiatric medicines, today announced financial results for the second quarter of 2026 and highlighted recent corporate and clinical progress.

Chevron Products Company, a division of Chevron U.S.A. Inc., will expand its North American base oils distribution network, strengthening customer access to premium base oils and process oils through complementary distribution agreements with HF Sinclair Lubricants & Specialties and Renkert Oil.

Air Industries Group (“Air Industries” or the “Company”) (NYSE American: AIRI), a leading manufacturer of precision components and assemblies for aerospace and Department of War prime contractors, today announced that the Securities and Exchange Commission (“SEC”) has notified the Company that it will review the Company’s Registration Statement on Form S-4 filed on July 22, 2026 relating to the Company’s pending merger with Tenax Aerospace Acquisition, LLC (“Tenax”).

Capital Square, a leading sponsor of tax-advantaged real estate investments and an active developer and manager of housing communities nationwide, today announced the launch of CS1031 Colony at Centerpointe Apartments, DST, a Delaware statutory trust offering ownership interests in a 255-unit, Class A-, garden-style apartment community located in the Richmond suburb of Midlothian, Virginia. The offering seeks to raise $42.95 million in equity from accredited investors seeking quality replacement properties for Section 1031 exchanges, along with others seeking stable cash flow and capital appreciation.

Ellington Credit Company (NYSE: EARN) (the "Company") today announced that it will release financial results for the quarter ended June 30, 2026 after market close on Wednesday, August 12, 2026. The Company will host a conference call to discuss its financial results at 11:00 a.m. Eastern Time on Thursday, August 13, 2026. To participate in the event by telephone, please dial (800) 343-4849 at least 10 minutes prior to the start time and reference the conference code EARNQ127. International callers should dial (203) 518-9848 and reference the same code. The conference call will also be webcast live and can be accessed via the "For Investors" section of the Company's website at www.ellingtoncredit.com. To listen to the live webcast, please visit www.ellingtoncredit.com at least 15 minutes prior to the start of the call to register, download, and install necessary audio software.

HONG KONG, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services, today announced that GPTBots.ai, its AI agent platform, has released LoopAgent — a production-grade execution engine that enables AI agents to autonomously handle complex, multi-step tasks across business systems.